Invesco’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Invesco’s Portfolio ORGS Stock Details ORGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,488	Closed	-$85K	–	4051
2021 Q1	$85K	Buy	1,488 +59	+4%	+$3.84K	﹤0.01%	3778
2020 Q4	$64K	Buy	+1,429	New	+$68.8K	﹤0.01%	3712

Other funds holding ORGS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Invesco's ORGS Position: Q2 2021 in Review

Invesco sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2021, closing a stake of 1,488 shares — an estimated $85K sold.

Invesco first reported a position in ORGS in Q4 2020 and held it in 2 quarters. The position peaked at $85K in Q1 2021. 33 funds tracked by Wall St. Rank hold ORGS as of Q2 2021.

Invesco reported no remaining Orgenesis Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Invesco sold 1,488 Orgenesis Inc. Common Stock shares in Q2 2021, an estimated $85K.
Invesco first reported a position in Orgenesis Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Invesco's Orgenesis Inc. Common Stock position peaked at $85K in Q1 2021.
33 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.